Sunrise completes $11.8 million placement:
This article was originally published in Clinica
Executive Summary
Sunrise Technologies International has completed an $11.8 million private placement at $3.50 per share. The Fremont, California-based company will use the funds to help it to gain pre-market approval for laser products for the treatment of hyperopia, to plan the launch of the Sunrise Hyperion LTK system - an office based instrument which uses two rings of laser energy - and to continue product development.